<div> <div>Dr Anu R I is a Clinician Scientist specialized in Cancer Omics, Therapeutics and</div> <div>Clinical Biochemistry (Chemical Pathology).</div> <div>Her primary translational research focus is in investigating molecular alterations in</div> <div>solid tumors, especially of breast, brain, colon and pancreas on a multi-omic level to</div> <div>discover prognostic and predictive biomarkers in patients with cancer. Her research</div> <div>also extends to genomic database creation (MUSTARD Database for targeted</div> <div>therapy) and signalling pathway network creation using computational oncology. She</div> <div>has completed PG courses from Harvard Medical School, namely, in High Impact</div> <div>Cancer Research (CBT-HICR) and Clinical Research Training.</div> <div>Dr Anu R I currently works as Head of Clinical Biochemistry, Specialist in Precision</div> <div>Oncology & Multi-omics in MVR Cancer Centre and Research Institute and as an</div> <div>International subject matter expert in Molecular Oncology and multi-omics.</div> <div>She is an active member of Analysis Working Groups: Multi-omics & Systems</div> <div>Biology and ALSDA formulated by NASA for Global networking and research on</div> <div>Space biology and Omics.</div> <div>Her MD in Clinical Biochemistry was obtained from Safdarjung hospital, New Delhi,</div> <div>with a Gold Medal. She has received numerous awards and accolades for</div> <div>experimental research on human genetics. Her vision encompasses laying the</div> <div>foundation of Precision Oncology and Multi-omics in India for advanced and tailored</div> <div>patient care and development of cost-effective diagnostic facilities for the socio-</div> <div>economically challenged patients worldwide</div> <div></div> <div></div> <div></div> <div></div> <div> <div><span style="text-decoration: underline;"><span style="color: #993300;"><strong>PUBLICATIONS</strong></span></span></div> <div></div> <div>1.Anu R I, Aastha Vatsyayan, Ambily Sivadas, Dileep Damodaran, Kurt van der Speeten. Multi-omic analysis classifies colorectal cancer into distinct angiogenic and immunogenic subtypes based on anatomical laterality [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 1154</div> <div></div> <div>2.Anu R I et al. Mutational Signatures, Variant Topography, and Signaling Pathways in Breast Cancer: A futuristic approach to personalized care. Translational Genomics. 2020. doi:10.9777/tg.2020.10001 </div> <div></div> <div>3.Anu R I, Gauri Mittal, Aastha Vatsyayan, Kavita Pandhare, Vinod Scaria. MUSTARD—a comprehensive resource of mutation-specific therapies in cancer, Database, Volume 2021, baab042, https://doi.org/10.1093/database/baab0423. </div> <div></div> <div>4. Cash, E., Sephton, S., Woolley, C. et al. The role of the circadian clock in cancer hallmark acquisition and immune-based cancer therapeutics. J Exp Clin Cancer Res 40, 119 (2021). https://doi.org/10.1186/s13046-021-01919-5 </div> <div></div> <div>5. RI Anu, Kaur C, Bhavsar P, Prasad J. Genotyping of Lipoprotein(a) Gene Variants in Coronary Artery Disease in Indian Population. Indian J Med Biochem 2021; 25 (2):76-82. doi: 10.5005/jp-journals-10054-0178 </div> <div></div> <div>6.Elbehi AM, Anu R I, Ekine-Afolabi B, Cash E. Emerging role of immune checkpoint inhibitors and predictive biomarkers in head and neck cancers. OralOncol.2020;109:104977. doi.org/10.1016/j.oraloncology.2020.104977 </div> <div></div> <div>7. Ekine-Afolabi BA, Njan AA, Rotimi SO, R I A, Elbehi AM, Cash E, Adeyeye A. The Impact of Diet on the Involvement of Non-Coding RNAs, Extracellular Vesicles, and Gut Microbiome-Virome in Colorectal Cancer Initiation and Progression. Front Oncol. 2020 Dec14;10:583372. doi: 10.3389/fonc.2020.583372. </div> <div></div> <div>8.The GUaRDIAN Consortium, Vinod Scaria, Sridhar Sivasubbu. Genomics of Rare Genetic diseases-experinces from India. Human Genomics. 2019;13(53). </div> <div></div> <div>9. Anu R I, Charanjeet Kaur, Prabhash Bhavsar, Jagdish Prasad. Genotyping of Lipoprotein (a) gene variants in Coronary Artery Disease in Indian Population. Indian Journal of Medical Biochemistry. Accepted for Publication. August 2021. </div> <div>10.Ajmal Sherif, Anu R I, Prasanth Parameswaran, Sajeevan K V, Sreedharan P S, Narayanankutty Warrier. When Lung cancer chokes your bowel: an interesting case report. IP International Journal of Medical Pediatrics and Oncology. 2020;6(1) Accepted for publication.</div> <div>11.Kabi BC, Bhavsar P, Anu RI, Tangdi D, Goswami R, Dudi P. Current Concepts of Vitamin B12 in various disorders: A review. Ind J Med Biochem 2014;18(1):3-13.</div> <div></div> <div>12.Tyagi N, Dudi P, Anu R I, Sahoo S S, Ramteke A, Kaur C. Adiponectin gene polymorphisms and Cardiovascular Disease. World Journal of Pharmacy and Pharmaceutical Sciences 2018; 7(2):1-8 </div> <div>13.Tyagi N, Bhadra J, Sahoo S, Anu R I, Bagra P, Kaur C. Adiponectin and IL-10 in Cardiovascular Disease. World Journal of Biomedical and Pharmaceutical Sciences 2018; 5(2):1-4</div> <div></div> <div> </div> <div></div> <div>Dr Anu R I, MD Biochemistry (Safdarjung Hospital)</div> <div>PGCerts Cancer Biology & Therapeutics, Clinical Research Training (Harvard Medical School). </div> <div>Specialist,</div> <div>Department of Cancer Biology & Therapeutics</div> <div>(Precision Oncology & Multi-omics clinic)</div> <div>Consultant and In-charge,</div> <div>Department of Clinical Biochemistry,</div> <div>MVR Cancer Center and Research Institute,</div> <div>Calicut, Kerala, India.</div> <div></div> <div>Member, Ames Life Sciences Data Archive (ALSDA) AWG</div> <div>Multi-omics and Systems Biology AWG, NASA Gene Lab.</div> <div></div> <div><span style="color: #993300;"><strong>Contact:</strong></span> 9971272384</div> <div><span style="color: #993300;"><strong>E-mail:</strong></span> dranu@mvrccri.co </div> </div> </div>
